Evidence for a common mechanism of action for antitumor and antibacterial agents that inhibit type II DNA topoisomerases
Open Access
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 265 (33) , 20496-20505
- https://doi.org/10.1016/s0021-9258(17)30531-8
Abstract
No abstract availableThis publication has 66 references indexed in Scilit:
- Design of NDA Intercalators To Overcome Topoisomerase II-Mediated Multidurg ResistanceJNCI Journal of the National Cancer Institute, 1990
- Purification and characterization of an altered topoisomerase II from a drug-resistant Chinese hamster ovary cell lineBiochemistry, 1989
- Ciprofloxacin and etoposide (VP16) produce a similar pattern of DNA cleavage in a plasmid of an archaebacteriumBiochemistry, 1989
- Topoisomerase II: A potential target for novel antifungal agentsBiochemical and Biophysical Research Communications, 1989
- DNA sequence preferences for the anti‐cancer drug mitoxanthrone and related anthraquinones revealed by DNase I footprintingFEBS Letters, 1986
- Identification of the specific sites of interaction between intercalating drugs and DNAChemico-Biological Interactions, 1984
- Sequence specificity of drug-DNA interactionsLife Sciences, 1983
- Antitumour activity of substituted 9-anilinoacridines—Comparison of in vivo and in vitro testing systemsPublished by Elsevier ,1981
- Gyrase-dependent initiation of bacteriophage T4 DNA replication: Interactions of Escherichia coli gyrase with novobiocin, coumermycin and phage DNA-delay gene productsJournal of Molecular Biology, 1979
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976